Biotest AG: Dividend Approval at Annual General Meeting

Biotest AG announced the approval of dividend distributions at its Annual General Meeting held on May 7, 2024. Shareholders approved a €0.04 per preference share dividend for the fiscal years 2023 and 2022. This decision was supported by 76.19% of the total share capital, with a near unanimous approval rate of 99.93%.

The meeting confirmed the actions of both the Executive and Supervisory Boards for the year 2023. Additionally, all other agenda items were broadly accepted in line with management's recommendations. The CEO of Biotest AG, Peter Janssen, provided a speech which is accessible on the company's website.